TrialBlood cancer journal2021

4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas.

Cheng Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.